US Broker Ratings

Supernus Pharmaceuticals, Inc. (SUPN) Stock Analysis: Evaluating the CNS Drug Maker’s Market Position and Growth Potential

Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN), a notable player in the healthcare sector specializing in drug manufacturing for central nervous system (CNS) diseases, has been capturing investor interest. With a current..

Beam Therapeutics Inc. (BEAM) Stock Analysis: Exploring a Potential 88% Upside in the Biotech Space

Beam Therapeutics Inc. (NASDAQ: BEAM), a pioneer in the field of biotechnology, is capturing investor attention with its innovative approach to precision genetic medicines. Headquartered in Cambridge, Massachusetts, Beam Therapeutics..

Protagonist Therapeutics, Inc. (PTGX) Stock Analysis: A Leading Biotech with an 8.75% Upside Potential

Protagonist Therapeutics, Inc. (NASDAQ: PTGX), a promising player in the biotechnology sector, is capturing investor attention with its innovative approach to developing peptide therapeutics for complex hematology, blood disorders, and..

Privia Health Group, Inc. (PRVA): Investor Outlook Reveals 32% Upside Potential

Privia Health Group, Inc. (NASDAQ: PRVA), a noted player in the healthcare sector, is drawing significant investor attention with its promising growth prospects and strategic positioning in the health information..

BioLife Solutions, Inc. (BLFS) Stock Analysis: Analyst Consensus Pointing to a 23.81% Upside

BioLife Solutions, Inc. (NASDAQ: BLFS) operates at the fascinating intersection of healthcare and technology, specifically within the medical instruments and supplies industry. With a market capitalization of $1.21 billion, this..

Brookdale Senior Living Inc. (BKD): Investor Outlook Amidst Strong Revenue Growth and Challenging Valuations

Brookdale Senior Living Inc. (NYSE: BKD), a prominent player in the healthcare sector, specializes in providing senior living communities across the United States. Despite its extensive market presence and a..

Novavax, Inc. (NVAX) Stock Analysis: Assessing a 40.92% Potential Upside in the Biotech Sector

Investors keen on exploring opportunities in the biotechnology sector should consider Novavax, Inc. (NASDAQ: NVAX), a company renowned for its innovative vaccine technologies. Headquartered in Gaithersburg, Maryland, Novavax is at..

Aveanna Healthcare Holdings Inc (AVAH) Stock Analysis: Exploring Upside Potential with a 16.80% Revenue Growth

Aveanna Healthcare Holdings Inc (NASDAQ: AVAH) presents an intriguing opportunity for investors interested in the healthcare sector, particularly within the medical care facilities industry. This Atlanta-based company, with a market..

Xenon Pharmaceuticals Inc. (XENE) Stock Analysis: Unpacking a 47% Upside Potential

Investors with an eye for growth opportunities in the biotech sector might find Xenon Pharmaceuticals Inc. (NASDAQ: XENE) an intriguing prospect. With a market cap of $2.88 billion and a..

Amneal Pharmaceuticals, Inc. (AMRX) Stock Analysis: A 25% Potential Upside Awaits Investors

Amneal Pharmaceuticals, Inc. (AMRX), a prominent player in the healthcare sector, is garnering attention from investors with a tantalizing 25% potential upside. As a global biopharmaceutical company headquartered in Bridgewater,..

89bio, Inc. (ETNB) Stock Analysis: Exploring a 125% Potential Upside in Clinical-Stage Biotech

89bio, Inc. (NASDAQ: ETNB) is capturing the attention of investors with its promising pipeline in the biotechnology sector. This clinical-stage biopharmaceutical company, established in 2018 and based in San Francisco,..

ImmunityBio, Inc. (IBRX) Stock Analysis: Unpacking a 282% Potential Upside

ImmunityBio, Inc. (NASDAQ: IBRX), a key player in the biotechnology sector, is garnering considerable attention from investors due to its robust growth potential and promising therapeutic developments. With a market..

Arcellx, Inc. (ACLX) Stock Analysis: Biotechnology Innovator with 44.55% Upside Potential

Arcellx, Inc. (NASDAQ: ACLX), a promising player in the biotechnology sector, is capturing the attention of investors with its innovative approach to immunotherapy. Operating out of Redwood City, California, this..

U.S. Physical Therapy, Inc. (USPH) Investor Outlook: Unpacking a 33.97% Potential Upside

U.S. Physical Therapy, Inc. (NYSE: USPH) is carving a niche in the healthcare sector, specifically within the medical care facilities industry. Based in Houston, Texas, and with a market capitalization..

Clover Health Investments, Corp (CLOV): Investor Outlook Highlights 21.67% Potential Upside

Clover Health Investments, Corp (CLOV) is a notable player in the healthcare sector, specifically within the healthcare plans industry. Based in Wilmington, Delaware, Clover Health focuses on providing Medicare Advantage..

MannKind Corporation (MNKD) Stock Analysis: Exploring an 89.79% Potential Upside in Biotech Innovation

MannKind Corporation (NASDAQ: MNKD), a prominent player in the healthcare sector, focuses on the development and commercialization of therapeutic products for endocrine and orphan lung diseases. With a market capitalization..

GoodRx Holdings, Inc. (GDRX) Investor Outlook: Exploring a 31.89% Potential Upside

GoodRx Holdings, Inc. (NASDAQ: GDRX) presents a compelling case for investors seeking opportunities in the healthcare sector, particularly within the health information services industry. With a market capitalization of $1.41..

Sotera Health Company (SHC) Stock Analysis: Navigating Growth in the Diagnostics & Research Sector

Sotera Health Company (NASDAQ: SHC) stands out in the healthcare sector, specifically within the diagnostics and research industry, with a market capitalization of $4.58 billion. As a provider of sterilization,..

Kiniksa Pharmaceuticals, Ltd. (KNSA) Stock Analysis: Strong Buy Ratings and 28.88% Potential Upside for Investors

Kiniksa Pharmaceuticals, Ltd. (KNSA), a standout player in the healthcare sector, is making significant strides in the drug manufacturing industry with a focus on specialty and generic pharmaceuticals. Based in..

Apogee Therapeutics, Inc. (APGE) Investor Outlook: 157.84% Potential Upside in the Biotech Frontier

Apogee Therapeutics, Inc. (NASDAQ: APGE) is capturing the attention of investors with its robust pipeline in the biotechnology sector, aiming to address various inflammatory and immunology indications. With a market..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds